Allspring Global Investments
TGTX icon

Allspring Global Investments’s TG Therapeutics TGTX Stock Holding History

Allspring Global Investments’s Portfolio TGTX Stock Details TGTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$12.2M Buy
227,430
+208,543
+1,104% +$8.53M 0.02% 666
2026
Q1 		$634K Buy
18,887
+1,769
+10% +$52.7K ﹤0.01% 1328
2025
Q4 		$501K Sell
17,118
-5,151
-23% -$168K ﹤0.01% 1377
2025
Q3 		$814K Sell
22,269
-209
-0.9% -$6.88K ﹤0.01% 1212
2025
Q2 		$796K Sell
22,478
-1,297
-5% -$48.3K ﹤0.01% 1225
2025
Q1 		$898K Buy
23,775
+8,338
+54% +$281K ﹤0.01% 1283
2024
Q4 		$465K Sell
15,437
-1,681
-10% -$48.2K ﹤0.01% 1476
2024
Q3 		$400K Sell
17,118
-1,195
-7% -$26.1K ﹤0.01% 1539
2024
Q2 		$326K Buy
18,313
+16,761
+1,080% +$267K ﹤0.01% 1605
2024
Q1 		$23.6K Sell
1,552
-164
-10% -$2.61K ﹤0.01% 2090
2023
Q4 		$29.3K Sell
1,716
-14,131
-89% -$164K ﹤0.01% 1933
2023
Q3 		$132K Sell
15,847
-960,768
-98% -$13.4M ﹤0.01% 1899
2023
Q2 		$24.3M Buy
976,615
+896,867
+1,125% +$23.2M 0.04% 541
2023
Q1 		$1.2M Buy
79,748
+73,287
+1,134% +$1.11M ﹤0.01% 1381
2022
Q4 		$76.4K Sell
6,461
-142
-2% -$1.03K ﹤0.01% 2178
2022
Q3 		$39K Buy
6,603
+5,533
+517% +$36.3K ﹤0.01% 2446
2022
Q2 		$4K Sell
1,070
-21,341
-95% -$133K ﹤0.01% 2626
2022
Q1 		$213K Sell
22,411
-1,381
-6% -$16K ﹤0.01% 2555
2021
Q4 		$452K Buy
+23,792
New +$618K ﹤0.01% 2337

Other funds holding TGTX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return
CAM
Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return

Allspring Global Investments's TGTX Position: Q2 2026 in Review

Allspring Global Investments increased its TG Therapeutics (TGTX) stake by 1,104% in Q2 2026, buying an estimated $8.53M and bringing the position to 227,430 shares worth $12.2M. The position accounts for 0.02% of the portfolio, ranked #666.

Allspring Global Investments first reported a position in TGTX in Q4 2021 and has held it in 19 quarters since. The position peaked at $24.3M in Q2 2023. 429 funds tracked by Wall St. Rank hold TGTX as of Q2 2026.

  • Allspring Global Investments held 227,430 shares of TG Therapeutics worth $12.2M as of Q2 2026.
  • Allspring Global Investments bought 208,543 TG Therapeutics shares in Q2 2026, an estimated $8.53M.
  • TG Therapeutics made up 0.02% of Allspring Global Investments's portfolio in Q2 2026, its #666 holding.
  • Allspring Global Investments first reported a position in TG Therapeutics in Q4 2021 and has held it in 19 quarters since.
  • Allspring Global Investments's TG Therapeutics position peaked at $24.3M in Q2 2023.
  • 429 funds tracked by Wall St. Rank held TG Therapeutics as of Q2 2026.

Based on Allspring Global Investments's 13F filing for Q2 2026, filed 13 Aug 2026.